FIELD: medicine.
SUBSTANCE: method involves introducing 4-(4-methylpiperazine-1-ylmethyl)-N-[4-methyl-3-(4-pyridine-3-yl)pyrimidine-2-ylamino)phenyl]benzamide of formula I or its pharmaceutically permissible salt for preparing pharmaceutical compositions for treating CD117-positive non-operable and/or metastatic malignant gastrointestinal stromal tumors.
EFFECT: enhanced effectiveness of treatment.
6 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF PROLIFERATIVE ARTHRITIS | 2003 |
|
RU2322238C2 |
| COMBINATION OF PYRIMIDYLAMINOBENZAMIDE AND IMANITIB DERIVATIVES FOR TREATMENT OR PREVENTION OF PROLIFERATIVE DISEASES | 2006 |
|
RU2430727C2 |
| AMIDE DERIVATIVE, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC AGENTS BASED ON THEREOF | 2003 |
|
RU2315043C2 |
| COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | 2006 |
|
RU2383545C2 |
| USING DERIVATIVES OF N-PHENYL-2-PYRIMIDINEAMINE AGAINST MASTOCYTE-BASE DISEASES SIMILAR TO ALLERGIC DISTURBANCE | 2002 |
|
RU2304436C2 |
| NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY | 2011 |
|
RU2598852C2 |
| NEW ANTHRANILAMIDOPYRIDINEUREAS AS VEGF RECEPTOR KINASE INHIBITORS | 2005 |
|
RU2415850C2 |
| COMPOUNDS AND COMPOSITIONS FOR MODULATING KINASE ACTIVITY OF EGFR MUTANTS | 2024 |
|
RU2838180C1 |
| PHARMACEUTICAL COMPOSITION OF IMATINIB OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD FOR PREPARING IT AND METHOD(S) OF TREATING | 2012 |
|
RU2517216C2 |
| TRIAZOLOPYRIDINE JAK INHIBITOR COMPOUNDS AND METHODS | 2009 |
|
RU2561104C2 |
